Abstract: Transmitter architectures designed to accommodate both constant and non-constant of envelope modulation schemes and capable of providing local oscillator carrier frequencies within any one of numerous desired frequency bands, thus allowing compliance with many different communication standards. One example of a programmable frequency synthesizer includes a plurality of transmitter components and a microcontroller coupled to the frequency synthesizer and to the plurality of transmitter components. The microcontroller is adapted to provide a frequency control signal to the frequency synthesizer to control a frequency of the local oscillator carrier frequency.

Abstract: Transmitter architectures designed to accommodate both constant and non-constant of envelope modulation schemes and capable of providing local oscillator carrier frequencies within any one of numerous desired frequency bands, thus allowing compliance with many different communication standards. One example of a programmable frequency synthesizer includes a plurality of transmitter components and a microcontroller coupled to the frequency synthesizer and to the plurality of transmitter components. The microcontroller is adapted to provide a frequency control signal to the frequency synthesizer to control a frequency of the local oscillator carrier frequency.

Abstract: The invention provides unit dosage forms, kits, and methods useful for treating viral infections.

Abstract: The present invention relates generally to a method of treatment and to agents useful for same. More particularly, the present invention contemplates a method for the treatment and/or prophylaxis of a nervous system disease, demyelinating disease and/or an inflammatory disease of either the central or peripheral nervous system such as but not limited to an encephalopathic condition and even more particularly an encephalomyelopathic condition. The present invention further provides the use of leukemia inhibitory factor or derivatives, homologous or analogues thereof in the manufacture of a medicament for the treatment and/or prophylaxis of a nervous system disease, demyelinating disease and/or an inflammatory disease of either the central or peripheral nervous system such as but not limited to an encephalopathic and more particularly an encephalomyelopathic condition.

Abstract: The invention relates to cyclic heteroaromatic compounds, containing at least one nitrogen atom, and to their use in the manufacture of medicaments for the treatment of diseases, related to adenosine receptor modulators, such as Alzheimer's disease, Parkinson's disease, neuroprotection, schizophrenia, anxiety, pain, respiration deficits, depression, asthma, allergic responses, hypoxia, ischaemia, seizure, substance abuse, sedation and they may be active as muscle relaxants, antipsychotics, anti epileptics, anticonvulsants and cardiaprotective agents.